Antiarrhythmic Drug Therapy

DRUG4 trials

Sponsors

IRCCS San Raffaele, Ottawa Heart Institute Research Corporation, Central Finland Hospital District, Affiliated Hospital of Nantong University

Conditions

Atrial FibrillationCardiovascular DiseasesMyocardial InfarctionVentricular ArrhythmiaVentricular TachyarrhythmiaVentricular Tachycardia

Phase 4

A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)

CompletedNCT00340314

IRCCS San RaffaeleAtrial Fibrillation

Start: 2005-01-31End: 2006-05-31Target: 198Updated: 2010-07-28

Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention

TerminatedNCT02114528

Ottawa Heart Institute Research CorporationVentricular Arrhythmia, Ventricular Tachycardia

Start: 2014-10-01End: 2015-11-01Updated: 2026-05-04

Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias

Central Finland Hospital DistrictMyocardial Infarction, Ventricular Tachyarrhythmia

Start: 2015-04-30End: 2018-06-30Target: 120Updated: 2016-09-01

Unknown Phase

CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories

Affiliated Hospital of Nantong UniversityCardiovascular Diseases

Start: 2022-05-01End: 2024-12-31Target: 200Updated: 2023-06-15

Related Papers

Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.

2011-09-2383 citations

A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.

2006-10-16476 citations